Title | Type | SJR | H index | Total Docs. (2002) | Total Docs. (3years) | Total Refs. (2002) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2002) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Critical Reviews in Toxicology | journal | 1.344 Q1 | 129 | 16 | 61 | 2773 | 275 | 61 | 3.83 | 173.31 | |
2 | Natural Product Reports | journal | 2.877 Q1 | 211 | 43 | 114 | 7090 | 641 | 113 | 5.92 | 164.88 | |
3 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.732 Q1 | 99 | 4 | 31 | 616 | 156 | 30 | 5.21 | 154.00 | |
4 | Expert Opinion on Emerging Drugs | journal | 0.270 Q3 | 54 | 25 | 68 | 2413 | 70 | 65 | 1.13 | 96.52 | |
5 | Expert Opinion on Therapeutic Targets | journal | 0.474 Q2 | 106 | 54 | 131 | 5107 | 108 | 131 | 1.04 | 94.57 | |
6 | Receptors and Channels | journal | 0.726 Q2 | 44 | 31 | 61 | 2887 | 82 | 59 | 1.03 | 93.13 | |
7 | Expert Opinion on Investigational Drugs | journal | 0.790 Q1 | 117 | 134 | 790 | 12336 | 1907 | 769 | 2.57 | 92.06 | |
8 | Toxin Reviews | journal | 0.311 Q3 | 54 | 20 | 51 | 1741 | 54 | 47 | 0.78 | 87.05 | |
9 | Clinical Pharmacokinetics | journal | 1.347 Q1 | 184 | 93 | 224 | 7889 | 1228 | 216 | 5.12 | 84.83 | |
10 | BioDrugs | journal | 0.329 Q3 | 79 | 47 | 230 | 3842 | 264 | 217 | 1.44 | 81.74 | |
11 | Reviews in Contemporary Pharmacotherapy | journal | 0.403 Q2 | 18 | 4 | 38 | 311 | 78 | 38 | 2.09 | 77.75 | |
12 | Expert Opinion on Biological Therapy | journal | 0.575 Q2 | 102 | 92 | 84 | 7032 | 195 | 82 | 2.32 | 76.43 | |
13 | Expert Opinion on Pharmacotherapy | journal | 0.423 Q2 | 93 | 160 | 273 | 11187 | 453 | 263 | 1.70 | 69.92 | |
14 | American Journal of Respiratory Medicine | journal | 34 | 51 | 0 | 3419 | 0 | 0 | 0.00 | 67.04 | ||
15 | Molecular Diagnosis and Therapy | journal | 68 | 36 | 185 | 2299 | 305 | 167 | 1.36 | 63.86 | ||
16 | Drug Safety | journal | 1.006 Q1 | 140 | 96 | 253 | 5584 | 1068 | 245 | 4.10 | 58.17 | |
17 | Adverse Drug Reactions and Toxicological Reviews | journal | 0.330 Q3 | 25 | 19 | 61 | 1078 | 53 | 29 | 0.65 | 56.74 | |
18 | Expert Opinion on Therapeutic Patents | journal | 0.435 Q2 | 88 | 132 | 419 | 7336 | 516 | 416 | 1.30 | 55.58 | |
19 | Expert Review of Vaccines | journal | 105 | 57 | 0 | 3050 | 0 | 0 | 0.00 | 53.51 | ||
20 | Current Opinion in Drug Discovery and Development | journal | 0.540 Q2 | 85 | 93 | 227 | 4784 | 394 | 213 | 1.97 | 51.44 | |
21 | International Journal of Neuropsychopharmacology | journal | 0.794 Q1 | 125 | 47 | 137 | 2392 | 305 | 131 | 2.47 | 50.89 | |
22 | Pharmacogenomics | journal | 1.058 Q1 | 100 | 84 | 75 | 4272 | 291 | 70 | 3.88 | 50.86 | |
23 | Current Opinion in Investigational Drugs | journal | 0.392 Q2 | 83 | 235 | 36 | 11722 | 21 | 33 | 0.58 | 49.88 | |
24 | Food and Chemical Toxicology | journal | 0.609 Q2 | 203 | 181 | 412 | 8645 | 844 | 401 | 1.81 | 47.76 | |
25 | Neuropsychopharmacology | journal | 2.161 Q1 | 249 | 203 | 511 | 9564 | 2500 | 477 | 4.60 | 47.11 | |
26 | Neuropharmacology | journal | 1.892 Q1 | 191 | 248 | 694 | 10924 | 2869 | 694 | 3.55 | 44.05 | |
27 | Current Opinion in Molecular Therapeutics | journal | 0.783 Q1 | 67 | 80 | 265 | 3419 | 606 | 246 | 2.58 | 42.74 | |
28 | Toxicology and Industrial Health | journal | 0.497 Q2 | 69 | 44 | 142 | 1842 | 232 | 138 | 0.52 | 41.86 | |
29 | Journal of Toxicology and Environmental Health - Part A: Current Issues | journal | 0.617 Q2 | 99 | 128 | 398 | 5227 | 632 | 396 | 1.37 | 40.84 | |
30 | Mutagenesis | journal | 0.706 Q2 | 102 | 79 | 246 | 3210 | 476 | 242 | 1.86 | 40.63 | |
31 | Cutaneous and Ocular Toxicology | journal | 0.111 Q4 | 37 | 24 | 140 | 971 | 11 | 122 | 0.15 | 40.46 | |
32 | Antiviral Chemistry and Chemotherapy | journal | 0.529 Q2 | 59 | 35 | 107 | 1389 | 224 | 107 | 1.95 | 39.69 | |
33 | Tetrahedron | journal | 1.673 Q1 | 236 | 1105 | 3368 | 43521 | 8475 | 3353 | 2.57 | 39.39 | |
34 | Toxicological Sciences | journal | 1.163 Q1 | 207 | 257 | 757 | 10012 | 2422 | 737 | 3.16 | 38.96 | |
35 | Autonomic and Autacoid Pharmacology | journal | 0.281 Q3 | 24 | 35 | 0 | 1360 | 0 | 0 | 0.00 | 38.86 | |
36 | Inhalation Toxicology | journal | 0.682 Q2 | 97 | 73 | 315 | 2827 | 426 | 304 | 1.33 | 38.73 | |
37 | PharmacoEconomics | journal | 0.787 Q1 | 118 | 107 | 355 | 4100 | 866 | 343 | 2.16 | 38.32 | |
38 | Comments on Toxicology | journal | 0.231 Q3 | 13 | 27 | 45 | 1001 | 17 | 33 | 0.60 | 37.07 | |
39 | Cytokines, Cellular and Molecular Therapy | journal | 0.528 Q2 | 28 | 21 | 55 | 776 | 87 | 55 | 1.31 | 36.95 | |
40 | Alimentary Pharmacology and Therapeutics, Supplement | journal | 0.900 Q1 | 69 | 66 | 110 | 2435 | 355 | 98 | 1.81 | 36.89 | |
41 | Immunopharmacology and Immunotoxicology | journal | 0.336 Q3 | 61 | 45 | 149 | 1659 | 159 | 149 | 0.78 | 36.87 | |
42 | Alcohol and Alcoholism | journal | 0.781 Q1 | 109 | 106 | 294 | 3816 | 638 | 267 | 2.00 | 36.00 | |
43 | Journal of Drug Targeting | journal | 0.614 Q1 | 107 | 75 | 134 | 2687 | 280 | 128 | 2.12 | 35.83 | |
44 | Toxicon | journal | 0.703 Q2 | 144 | 199 | 523 | 7101 | 1024 | 509 | 1.98 | 35.68 | |
45 | Addictive Behaviors | journal | 0.764 Q1 | 149 | 74 | 268 | 2584 | 407 | 266 | 1.37 | 34.92 | |
46 | Pharmacogenomics Journal | journal | 0.547 Q2 | 95 | 63 | 56 | 2185 | 103 | 50 | 1.84 | 34.68 | |
47 | Clinical and Experimental Pharmacology and Physiology | journal | 0.675 Q2 | 115 | 193 | 597 | 6677 | 1036 | 596 | 1.54 | 34.60 | |
48 | Chemical Biology and Drug Design | journal | 0.691 | 91 | 71 | 355 | 2386 | 615 | 345 | 1.71 | 33.61 | |
49 | BMC Pharmacology | journal | 0.192 Q3 | 48 | 21 | 13 | 702 | 11 | 13 | 0.85 | 33.43 | |
50 | Environmental Pollution | journal | 1.254 Q1 | 301 | 307 | 624 | 10193 | 1362 | 603 | 2.10 | 33.20 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®